{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:00:42Z","timestamp":1785171642191,"version":"3.55.0"},"posted":{"date-parts":[[2025,11,20]]},"group-title":"In Review","reference-count":33,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,10,31]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Background\nMedications for opioid use disorder (MOUD) have been proven to be the most effective method for treating individuals with opioid use disorder (OUD). Individuals who are retained on methadone and buprenorphine treatment have a decreased risk of mortality when compared to others with OUD. However, many individuals in need of MOUD face transportation barriers that prevent them from having the requisite access to treatment.\nMethods\nAs part of the evidence-based practices (EBPs) implemented throughout the HEALing (Helping to End Addiction Long-term\n                  <italic>\u00ae<\/italic>\n                  ) Communities Study (HCS), strategies to reduce transportation barriers to receiving methadone and buprenorphine at partner organizations were identified and implemented. Multiple strategies were employed including transportation agency contracts, bus passes, rideshare services, leased agency vans, and fuel cards. This study provides a description of the number of unique riders, including demographic and geographic characteristics and the costs of providing these transportation services across participating counties.\nResults\nThroughout 2023, we partnered with thirty agencies across eight counties to administer $437,481.69 in transportation support services to 7,923 individuals. These services were distributed primarily to individuals who were white (81.8%; 6,483), female (51.9%; 4,112) and between the ages of 35\u201354 (59.8%; 4,737). The number of individuals reached and expenses were largest among the five urban counties (5,999; $318,317.15), which averaged $53.06 per person. Rural counties averaged $61.94 per person reached (1,924; $119,164.54). A survey was administered among a subpopulation of these individuals, and among this group, 813 of 958 (84.9%) identified transportation as a major barrier to obtaining\/staying in care with MOUD. Within this subgroup, 262 individuals (27.3%) made 377 unique transportation service requests (27.7% of all subgroup requests), which included vehicle repairs (81), peer recovery drivers for rides directly to MOUD appointments (73), and bus passes (70).\nConclusions\nBy gaining an understanding of the population benefiting from these services and the costs required to address this barrier to care, we may more effectively inform decision-makers on the resources needed to link and retain individuals in treatment.\nTrial registration\nClinicalTrials.gov, NCT04111939. Registered 30 September 2019, https\/\/clinicaltrials.gov\/ct2\/show\/NCT04111939\n                <\/p>","DOI":"10.21203\/rs.3.rs-7999770\/v1","type":"posted-content","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:55:22Z","timestamp":1763646922000},"source":"Crossref","is-referenced-by-count":1,"title":["Analysis of the Costs and Reach of Transportation Services to Reduce Barriers to Opioid Use Disorder (OUD) Treatment: Evidence from the Kentucky HEALing Communities Study"],"prefix":"10.21203","author":[{"given":"Drew D.","family":"Speer","sequence":"first","affiliation":[{"name":"University of Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L.","family":"Bush","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don Lochana","family":"Ekanayake","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Nakayima","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Goetz","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Miles","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Larimore","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah K.","family":"Knudsen","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Walsh","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"McCollister","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"U.S. Overdose Deaths Decrease in 2023, First Time Since 2018 [Internet]. 2024 [cited 2024 May 21]. Available from: https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2024\/20240515.htm"},{"key":"ref2","author":"Haffajee R","year":"2021","unstructured":"Haffajee R, Sherry T, Dubenitz J, White J, Schwartz D, Stoller B et al. U.S. Department of Health and Human Services Overdose Prevention Strategy [Internet]. Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Service; 2021. Available from: https:\/\/aspe.hhs.gov\/sites\/default\/files\/documents\/101936da95b69acb8446a4bad9179cc0\/overdose-prevention-strategy.pdf"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"e1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder","volume":"3","author":"Wakeman SE","year":"2020","unstructured":"Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, et al. Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. JAMA Netw Open. 2020;3(2):e1920622.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"e223821","DOI":"10.1001\/jamanetworkopen.2022.3821","article-title":"Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019","volume":"5","author":"Mauro PM","year":"2022","unstructured":"Mauro PM, Gutkind S, Annunziato EM, Samples H. Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019. JAMA Netw Open. 2022;5(3):e223821.","journal-title":"JAMA Netw Open"},{"key":"ref5","author":"Dowell D","year":"2022","unstructured":"Dowell D. Treatment for Opioid Use Disorder: Population Estimates \u2014 United States, 2022. MMWR Morb Mortal Wkly Rep [Internet]. 2024 [cited 2024 Jul 10];73. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/73\/wr\/mm7325a1.htm"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/ADM.0000000000000739","article-title":"Retention Strategies for Medications for Opioid Use Disorder in Adults: A Rapid Evidence Review","volume":"15","author":"Chan B","year":"2021","unstructured":"Chan B, Gean E, Arkhipova-Jenkins I, Gilbert J, Hilgart J, Fiordalisi C, et al. Retention Strategies for Medications for Opioid Use Disorder in Adults: A Rapid Evidence Review. J Addict Med. 2021;15(1):74.","journal-title":"J Addict Med"},{"key":"ref7","author":"Schweninger E","unstructured":"Schweninger E, Edmunds M, Atherton E, Transportation. A Community Driver of Health."},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s10900-013-9681-1","article-title":"Traveling Towards Disease: Transportation Barriers to Health Care Access","volume":"38","author":"Syed ST","year":"2013","unstructured":"Syed ST, Gerber BS, Sharp LK. Traveling Towards Disease: Transportation Barriers to Health Care Access. J Community Health. 2013;38(5):976.","journal-title":"J Community Health"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2105\/AJPH.2020.305579","article-title":"Transportation Barriers to Health Care in the United States: Findings From the National Health Interview Survey, 1997\u20132017","volume":"110","author":"Wolfe MK","year":"2020","unstructured":"Wolfe MK, McDonald NC, Holmes GM. Transportation Barriers to Health Care in the United States: Findings From the National Health Interview Survey, 1997\u20132017. Am J Public Health. 2020;110(6):815\u201322.","journal-title":"Am J Public Health"},{"key":"ref10","unstructured":"RWJF [Internet]. [cited 2025 Feb 4]. More than One in Five Adults Forgo Healthcare Because of Transportation Barriers. Available from: https:\/\/www.rwjf.org\/content\/rwjf-web\/us\/en\/insights\/our-research\/2023\/04\/more-than-one-in-five-adults-with-limited-public-transit-access-forgo-healthcare-because-of-transportation-barriers.html"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.healthplace.2010.06.012","article-title":"Black residential segregation, disparities in spatial access to health care facilities, and late-stage breast cancer diagnosis in metropolitan Detroit","volume":"16","author":"Dai D","year":"2010","unstructured":"Dai D. Black residential segregation, disparities in spatial access to health care facilities, and late-stage breast cancer diagnosis in metropolitan Detroit. Health Place. 2010;16(5):1038\u201352.","journal-title":"Health Place"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.puhe.2015.04.001","article-title":"Exposing some important barriers to health care access in the rural USA","volume":"129","author":"Douthit N","year":"2015","unstructured":"Douthit N, Kiv S, Dwolatzky T, Biswas S. Exposing some important barriers to health care access in the rural USA. Public Health. 2015;129(6):611\u201320.","journal-title":"Public Health"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/00330120701724087","article-title":"Late-Stage Breast Cancer Diagnosis and Health Care Access in Illinois\u2217","volume":"60","author":"Wang F","year":"2008","unstructured":"Wang F, McLafferty S, Escamilla V, Luo L. Late-Stage Breast Cancer Diagnosis and Health Care Access in Illinois\u2217. Prof Geogr. 2008;60(1):54\u201369.","journal-title":"Prof Geogr"},{"key":"ref14","author":"CCM KA BSN RN","unstructured":"CCM KA BSN RN, BC RN. How to Address SDOH Transportation Barriers [Internet]. [cited 2025 Feb 4]. Available from: https:\/\/www.thoroughcare.net\/blog\/address-sdoh-transportation-barriers"},{"key":"ref15","unstructured":"Social Determinants of Health Literature Summaries. - Healthy People 2030 | odphp.health.gov [Internet]. [cited 2025 Feb 4]. Available from: https:\/\/odphp.health.gov\/healthypeople\/priority-areas\/social-determinants-health\/literature-summaries"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s10900-018-0572-3","article-title":"A systematic review of interventions to minimize transportation barriers among people with chronic diseases","volume":"44","author":"Starbird LE","year":"2019","unstructured":"Starbird LE, DiMaina C, Sun CA, Han HR. A systematic review of interventions to minimize transportation barriers among people with chronic diseases. J Community Health. 2019;44(2):400.","journal-title":"J Community Health"},{"issue":"2","key":"ref17","first-page":"178","article-title":"Measuring Health-related Transportation Barriers in Urban Settings","volume":"18","author":"Locatelli SM","year":"2017","unstructured":"Locatelli SM, Sharp LK, Syed ST, Bhansari S, Gerber BS. Measuring Health-related Transportation Barriers in Urban Settings. J Appl Meas. 2017;18(2):178.","journal-title":"J Appl Meas"},{"issue":"8","key":"ref18","first-page":"1090","article-title":"Evaluating The Veterans Affairs Rideshare Program For Homeless Patients","volume":"43","author":"Tsai J","year":"2024","unstructured":"Tsai J, Szymkowiak D, Beydoun H, Dasilva L, Transportation As A, Determinant Of Health. Evaluating The Veterans Affairs Rideshare Program For Homeless Patients. Health Aff (Millwood). 2024;43(8):1090\u20139.","journal-title":"Health Aff (Millwood)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13011-025-00644-y","article-title":"Barriers and facilitators to scaling up medications for opioid use disorder in Kentucky: qualitative perspectives of treatment organization staff","volume":"20","author":"Knudsen HK","year":"2025","unstructured":"Knudsen HK, Andrews-Higgins S, Back-Haddix S, Lofwall MR, Fanucchi L, Walsh SL. Barriers and facilitators to scaling up medications for opioid use disorder in Kentucky: qualitative perspectives of treatment organization staff. Subst Abuse Treat Prev Policy. 2025;20:15.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo L","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550.","journal-title":"BMJ"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.tranpol.2024.08.001","article-title":"Affordable transportation access to treatment for opioid use disorder","volume":"156","author":"Ngo NS","year":"2024","unstructured":"Ngo NS, Anand K. Affordable transportation access to treatment for opioid use disorder. Transp Policy. 2024;156:152\u201363.","journal-title":"Transp Policy"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"108093","DOI":"10.1016\/j.jsat.2020.108093","article-title":"Geographic access to buprenorphine prescribers for patients who use public transit","volume":"117","author":"Drake C","year":"2020","unstructured":"Drake C, Donohue J, Nagy D, Mair C, Kraemer K, Wallace D. Geographic access to buprenorphine prescribers for patients who use public transit. J Subst Abuse Treat. 2020;117:108093.","journal-title":"J Subst Abuse Treat"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"108727","DOI":"10.1016\/j.drugalcdep.2021.108727","article-title":"Access to medication-assisted treatment in the United States: Comparison of travel time to opioid treatment programs and office-based buprenorphine treatment","volume":"224","author":"Amiri S","year":"2021","unstructured":"Amiri S, Hirchak K, McDonell MG, Denney JT, Buchwald D, Amram O. Access to medication-assisted treatment in the United States: Comparison of travel time to opioid treatment programs and office-based buprenorphine treatment. Drug Alcohol Depend. 2021;224:108727.","journal-title":"Drug Alcohol Depend"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"108335","DOI":"10.1016\/j.drugalcdep.2020.108335","article-title":"The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices","volume":"217","author":"HEALing Communities Study Consortium","year":"2020","unstructured":"HEALing Communities Study Consortium. The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices. Drug Alcohol Depend. 2020;217:108335.","journal-title":"Drug Alcohol Depend"},{"key":"ref25","author":"Knudsen HK","year":"2024","unstructured":"Knudsen HK, Andrews-Higgins S, Back-Haddix S, Lofwall MR, Fanucchi L, Walsh SL. Scaling up medications for opioid use disorder in Kentucky: Qualitative perspectives of treatment organizations. Res Sq. 2024;rs.3.rs-5440415."},{"key":"ref26","author":"Fallin-Bennett A","year":"2024","unstructured":"Fallin-Bennett A, Moffitt T, Walsh SL, Lofwall M, Miles J, Underwood C et al. We Drove to the Moon: Ensuring Methadone Access in Rural Kentucky through Peer Transportation. J Addict Med. 2024;10.1097\/ADM.0000000000001459."},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris PA","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research Electronic Data Capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377\u201381.","journal-title":"J Biomed Inf"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap Consortium: Building an International Community of Software Platform Partners","volume":"95","author":"Harris PA","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap Consortium: Building an International Community of Software Platform Partners. J Biomed Inf. 2019;95:103208.","journal-title":"J Biomed Inf"},{"key":"ref29","author":"Division H","year":"2019","unstructured":"National Academies of Sciences E, Division H, Policy M, on HS B, Disorder C on MAT for, Mancher OU, Leshner M. AI. Barriers to Broader Use of Medications to Treat Opioid Use Disorder. In: Medications for Opioid Use Disorder Save Lives [Internet]. National Academies Press (US); 2019 [cited 2025 Jul 3]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK541389\/"},{"key":"ref30","author":"Telehealth","unstructured":"Telehealth. and medications for opioid use disorder [Internet]. [cited 2025 Feb 4]. Available from: https:\/\/telehealth.hhs.gov\/providers\/best-practice-guides\/telehealth-substance-use-disorder\/telehealth-and-medications-opioid"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"e12854","DOI":"10.1111\/jrh.12854","article-title":"A multilevel analysis of changing telehealth availability in opioid use disorder treatment settings: Conditional effects of rurality, the number and types of medication for opioid use disorder available, and time, US, 2016\u20132023","volume":"41","author":"Pro G","year":"2025","unstructured":"Pro G, Cantor J, Willis D, Gu M, Fairman B, Baloh J, et al. A multilevel analysis of changing telehealth availability in opioid use disorder treatment settings: Conditional effects of rurality, the number and types of medication for opioid use disorder available, and time, US, 2016\u20132023. J Rural Health Off J Am Rural Health Assoc Natl Rural Health Care Assoc. 2025;41(1):e12854.","journal-title":"J Rural Health Off J Am Rural Health Assoc Natl Rural Health Care Assoc"},{"key":"ref32","unstructured":"Kentucky General Assembly. Kentucky Legislative Research Commission. 2024 [cited 2024 Dec 8]. Title 908 Chap. 2 Regulation 220 \u2022 Kentucky Administrative Regulations \u2022 Legislative Research Commission. Available from: https:\/\/apps.legislature.ky.gov\/law\/kar\/titles\/908\/002\/220\/"},{"key":"ref33","unstructured":"National Quality Forum. Quality ID #468: Continuity of Pharmacotherapy for Opioid Use Disorder (OUD) - National Quality Strategy Domain: Effective Clinical Care; Meaningful Measure Area: Prevention and Treatment of Opioid and Substance Use Disorders. [Internet]. 2022. Available from: https:\/\/qpp.cms.gov\/docs\/QPP_quality_measure_specifications\/CQM-Measures\/2019_Measure_468_MIPSCQM.pdf"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7999770\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7999770\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:05:56Z","timestamp":1785168356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7999770\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":33,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-7999770\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s13722-026-00702-1","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,11,20]]},"subtype":"preprint"}}